RxDoctor Payments Data

Jessica Nance, MD

Neurology with Special Qualifications in Child Neurology · Baltimore, MDNPI 1033376876

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Sarepta Therapeutics, Inc. at 49.9% of the total. 2025 is the largest year on record at $7,699, 4.1 times the $1,900 reported in 2019. Among neurology with special qualifications in child neurology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,571in general payments, 2019–2025

Across 20 payments — averaging $928.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sarepta Therapeutics, Inc.$9K
  • Catalyst Pharmaceuticals, Inc.$7K
  • Mallinckrodt Enterprises LLC$2K
  • Biogen$36
$665,988in research payments, 2019–2025

Across 393 payments — averaging $1694.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sarepta Therapeutics, Inc.$666K

What the payments were for

  • Consulting fees$10,34056%
  • Speaking & faculty fees$6,00032%
  • Travel & lodging$1,2517%
  • Food & beverage$9805%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,571 in reported general payments places this provider in the 95th percentile of 36 neurology with special qualifications in child neurology providers in Maryland.

See all neurology with special qualifications in child neurology providers in Maryland

Medicare billing

Part B allowed, 2024
$32,905
Medicare patients
105
Services billed
797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →